LGNZZ
LIGAND PHARMS BETA CVR—+0.00 (—)Prev Close—·MCap$1.5M·P/E—·Vol—·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
3
$9.99M
◆
Net Activity
Net Seller
$9.99M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at LIGAND PHARMS BETA CVR (LGNZZ) has been exclusively selling, with 0 insider purchases totaling $0.00 and 3 insider sales totaling $9.99M. The most recent insider transaction was by Davis Todd C (Chief Executive Officer), who sold $6.04M worth of shares on Feb 14, 2026. LIGAND PHARMS BETA CVR operates in the Healthcare sector, within the Medical - Pharmaceuticals industry, with a market cap of $1.5M.
LGNZZ Insider Trading Activity
LGNZZ Insider Buying Activity
The following table shows recent insider purchases of LIGAND PHARMS BETA CVR (LGNZZ) stock reported via SEC Form 4 filings.
No insider buying activity found for LGNZZ in the last 12 months.
LGNZZ Insider Selling Activity
The following table shows recent insider sales of LIGAND PHARMS BETA CVR (LGNZZ) stock reported via SEC Form 4 filings.